Back to Search
Start Over
Morphine for Refractory Dyspnea in Interstitial Lung Disease: A Phase I Study (JORTC-PAL 05)
- Source :
- Journal of Palliative Medicine. 21:1718-1723
- Publication Year :
- 2018
- Publisher :
- Mary Ann Liebert Inc, 2018.
-
Abstract
- Background: Dyspnea is common in interstitial lung disease (ILD) patients and often refractory to conventional treatment. Little is known regarding the safety of systemic morphine in ILD p...
- Subjects :
- Male
medicine.medical_specialty
behavioral disciplines and activities
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Refractory
Internal medicine
Humans
Medicine
Drug Dosage Calculations
030212 general & internal medicine
General Nursing
Aged
Aged, 80 and over
Clinical Trials, Phase I as Topic
Morphine
business.industry
Interstitial lung disease
Conventional treatment
General Medicine
Middle Aged
respiratory system
medicine.disease
respiratory tract diseases
Phase i study
body regions
Dyspnea
Anesthesiology and Pain Medicine
030228 respiratory system
Female
Lung Diseases, Interstitial
business
medicine.drug
Subjects
Details
- ISSN :
- 15577740 and 10966218
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Journal of Palliative Medicine
- Accession number :
- edsair.doi.dedup.....70e623ca83596180649621dcfb93a056